Skip to main navigation Skip to search Skip to main content

Hiponatremia sintomática inducida por citalopram y escitalopram

Translated title of the contribution: Citalopram- and escitalopram-induced symptomatic hyponatremia
  • University of Girona

Research output: Contribution to journalScientific articlepeer-review

1 Citation (Scopus)

Abstract

We report the cases of 2 patients who developed syndrome of inappropriate antidiuretic hormone secretion (SIADH) after initiating therapy with the selective serotonin reuptake inhibitors, citalopram and escitalopram. Both the patients were women, aged 65 and 81 years old. The first consulted for headache, nausea and vomiting and the second for asthenia and malaise. Both were under treatment for depression with citalopram (20 mg/day) and escitalopram (10 mg/day), respectively. We review the literature on SIADH induced by citalopram and escitalopram and the pathophysiological mechanisms of this syndrome.

Translated title of the contributionCitalopram- and escitalopram-induced symptomatic hyponatremia
Original languageSpanish
Pages (from-to)178-180
Number of pages3
JournalEndocrinologia y Nutricion
Volume55
Issue number4
DOIs
Publication statusPublished - 1 Apr 2008
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Citalopram- and escitalopram-induced symptomatic hyponatremia'. Together they form a unique fingerprint.

Cite this